PER 0.00% 10.0¢ percheron therapeutics limited

anp chart, page-723

  1. 720 Posts.
    lightbulb Created with Sketch. 210
    Neither ANP nor Ionis own ATL1102. ATL1102 patent ran out in 2019.

    ANP own/have applied for a number of patents on using ATL1102 in various applications/mechanisms including DMD.


    Last edited by BoomCrashOffera: 30/05/23
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.